Terms: = Colorectal cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
287 results:
1. Real-world data evaluating Guy's rapid diagnostic clinic as an alternate pathway for patients with FIT levels below 10.
Monroy-Iglesias MJ; Martin S; Cargaleiro C; Jones G; Steward L; Murtagh C; Bruno F; Millwaters J; Schizas A; Watson H; Haire A; Haire K; Moss CL; Russell B; Srirajaskanthan R; Van Hemelrijck M; Dolly S
BMJ Open; 2024 Apr; 14(4):e080285. PubMed ID: 38626962
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of 30-day, 90-day, and 1-year mortality after colorectal cancer surgery using a data-driven approach.
Bräuner KB; Tsouchnika A; Mashkoor M; Williams R; Rosen AW; Hartwig MFS; Bulut M; Dohrn N; Rijnbeek P; Gögenur I
Int J Colorectal Dis; 2024 Feb; 39(1):31. PubMed ID: 38421482
[TBL] [Abstract] [Full Text] [Related]
3. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
4. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of silver-nanoparticles and whey-encapsulated particles from olive leaf water extracts: Characteristics and biological activity.
Mansour HMM; Shehata MG; Abdo EM; Sharaf MM; Hafez EE; Galal Darwish AM
PLoS One; 2023; 18(12):e0296032. PubMed ID: 38109310
[TBL] [Abstract] [Full Text] [Related]
6. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.
Zheng P; Ye C; Liu H; Gao X; Huang H
Int J Colorectal Dis; 2023 Dec; 39(1):3. PubMed ID: 38091096
[TBL] [Abstract] [Full Text] [Related]
8. Self-supervised representation learning using feature pyramid siamese networks for colorectal polyp detection.
Gan T; Jin Z; Yu L; Liang X; Zhang H; Ye X
Sci Rep; 2023 Dec; 13(1):21655. PubMed ID: 38066207
[TBL] [Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis.
Kwakman JJM; Bond MJG; Demichelis RM; Koopman M; Hompes R; Elferink MAG; Punt CJA
Eur J Cancer; 2024 Jan; 197():113466. PubMed ID: 38061213
[TBL] [Abstract] [Full Text] [Related]
10. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
[TBL] [Abstract] [Full Text] [Related]
11. Development of a joint prediction model based on both the radiomics and clinical factors for preoperative prediction of circumferential resection margin in middle-low rectal cancer using T2WI images.
Ju Y; Zheng L; Qi W; Tian G; Lu Y
Med Phys; 2024 Apr; 51(4):2563-2577. PubMed ID: 37987563
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative contrast-enhanced CT imaging and clinicopathological characteristics analysis of mismatch repair-deficient colorectal cancer.
Chen S; Du W; Cao Y; Kong J; Wang X; Wang Y; Lu Y; Li X
Cancer Imaging; 2023 Oct; 23(1):97. PubMed ID: 37828626
[TBL] [Abstract] [Full Text] [Related]
13. Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.
Tharmaseelan H; Vellala AK; Hertel A; Tollens F; Rotkopf LT; Rink J; Woźnicki P; Ayx I; Bartling S; Nörenberg D; Schoenberg SO; Froelich MF
Cancer Imaging; 2023 Oct; 23(1):95. PubMed ID: 37798797
[TBL] [Abstract] [Full Text] [Related]
14. Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles.
He C; Huang Q; Zhong S; Chen LS; Xiao H; Li L
World J Surg Oncol; 2023 Oct; 21(1):312. PubMed ID: 37779184
[TBL] [Abstract] [Full Text] [Related]
15. The predictive value of advanced lung cancer inflammation index for short-term outcomes and prognosis of colorectal cancer patients who underwent radical surgery.
Zhang B; Li ZW; Tong Y; Yuan C; Liu XY; Wei ZQ; Zhang W; Peng D
Int J Clin Oncol; 2023 Dec; 28(12):1616-1624. PubMed ID: 37700210
[TBL] [Abstract] [Full Text] [Related]
16. The efficacy and safety of cold snare polypectomy with submucosal injection for the removal of polyps less than 20 mm in size: a systematic review and meta-analysis.
Liang Z; Wei Y; Zhang S; Li P
J Gastroenterol Hepatol; 2023 Nov; 38(11):1892-1899. PubMed ID: 37608577
[TBL] [Abstract] [Full Text] [Related]
17. A national evaluation of adjuvant chemotherapy in pT4N0M0 colon cancer from the National cancer Database.
Reif de Paula T; Keller DS
J Natl Cancer Inst; 2023 Dec; 115(12):1616-1625. PubMed ID: 37584736
[TBL] [Abstract] [Full Text] [Related]
18. Intergenic CircRNA
Long F; Li L; Xie C; Ma M; Wu Z; Lu Z; Liu B; Yang M; Zhang F; Ning Z; Zhong C; Yu B; Liu S; Wan L; Tian B; Yang K; Guo Y; Chen M; Chou J; Li X; Hu G; Lin C; Zhang Y
Int J Biol Sci; 2023; 19(12):3781-3803. PubMed ID: 37564198
[TBL] [Abstract] [Full Text] [Related]
19. Differentially expressed miR-4310 functions as a tumor suppressor in colorectal cancer.
Jiang Z; Yi P; You J; Cai E
Technol Health Care; 2024; 32(2):1043-1053. PubMed ID: 37545284
[TBL] [Abstract] [Full Text] [Related]
20. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
[TBL] [Abstract] [Full Text] [Related]
[Next]
